For example, the insulin and insulin-like growth factor-1 receptor (IGF-1R) signaling pathways are known to enhance the development and progression of PDAC by promoting tumor growth and metastasis and by driving therapy resistance [6]. Here, IGF1R is linked to neoplasm.